Related Experiment Video

Updated: Jul 19, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Human immunodeficiency virus and hepatitis C virus co-infection

Stacey R Vlahakis1

  • 1Mayo Clinic College of Medicine, Rochester, Minnesota, USA. vlahakis.stacey@mayo.edu

Le Journal Medical Libanais. the Lebanese Medical Journal
|November 8, 2006
PubMed

Insights

Hepatitis C virus (HCV) co-infection is common and serious in HIV-infected individuals, leading to increased liver disease and mortality. Physicians must prioritize addressing HCV in patients with HIV.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) is a primary cause of liver disease and cancer globally.
  • HCV shares transmission routes with HIV, leading to high co-infection rates, especially in intravenous drug users.
  • Advances in HIV treatment have improved survival, making HCV co-infection a leading cause of morbidity and mortality.

Purpose of the Study:

  • To highlight the significant clinical impact of HCV co-infection in HIV-infected individuals.
  • To emphasize the growing burden of HCV-related liver disease in the context of improved HIV management.
  • To underscore the necessity for physicians to manage HCV in patients with HIV.

Main Methods:

  • Literature review and clinical data synthesis on HIV/HCV co-infection.
  • Analysis of epidemiological trends and clinical outcomes.
  • Review of treatment implications for co-infected patients.

Main Results:

  • Approximately 30% of HIV-infected individuals are co-infected with HCV, rising to 90% in intravenous drug users.
  • HCV co-infection is now a major cause of illness and death in HIV patients, surpassing opportunistic infections.
  • HIV accelerates HCV liver disease progression and viremia, while HCV can impede HIV therapy.

Conclusions:

  • HIV/HCV co-infection is a prevalent and critical health issue requiring urgent medical attention.
  • Effective management of HCV is essential for improving long-term outcomes in the growing population of HIV-survivors.
  • Physicians globally must integrate HCV screening and treatment into the care of HIV-infected patients.

More Related Videos

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...